Medline Inc. (MDLN)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
In fiscal 2025, Medline Inc. reported revenue of $28.43B, up 11.5% from the prior year. The company was profitable, with a net margin of 4.1% and a gross margin of 26.4%. It held $38.48B in total assets against $19.20B in total liabilities.
Key ratios (FY2025)
26.4%
Gross margin
7.8%
Operating margin
4.1%
Net margin
10.8%
Return on equity
+11.5%
Revenue growth (YoY)
| Metric (FY) | 2025 | 2024 | 2023 |
|---|---|---|---|
| Revenue | $28.43B | $25.51B | $23.23B |
| Cost of Revenue | $20.91B | $18.53B | $17.35B |
| Gross Profit | $7.52B | $6.98B | $5.88B |
| Operating Income | $2.21B | $2.15B | $1.25B |
| Net Income | $1.16B | — | — |
| EPS (Diluted) | $-0.01 | — | — |
| Total Assets | $38.48B | $35.98B | — |
| Total Liabilities | $19.20B | $19.45B | — |
| Shareholders' Equity | $10.74B | — | — |
| Cash & Equivalents | $1.94B | $199.00M | — |
| Operating Cash Flow | $1.74B | $1.77B | $1.69B |
| Capital Expenditures | $447.00M | $354.00M | $275.00M |
| Shares Outstanding | 810.00M | — | — |